News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Neill Vincent
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 521 restricted stock units
@ $0 |
|
| 03/16/2023 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 845 shares
@ $19.695, valued at
$16.6k
Exercised 2,084 restricted stock units
@ $0
Granted 9,000 restricted stock units
@ $0
Granted 32,000 options to buy
@ $19.6, valued at
$627.2k
|
|
| 01/24/2023 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 29,713 shares
@ $30, valued at
$891.4k
Exercised 29,713 options to buy
@ $0.41, valued at
$12.2k
|
|
| 03/16/2022 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 8,337 restricted stock units
@ $0 |
|
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2021 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 6,758 shares
@ $48.43, valued at
$327.3k
Sold 12,665 shares
@ $49.27, valued at
$624k
Sold 2,700 shares
@ $50.38, valued at
$136k
Sold 1,500 shares
@ $51.45, valued at
$77.2k
Sold 1,377 shares
@ $52.45, valued at
$72.2k
Exercised 25,000 options to buy
@ $0.41, valued at
$10.3k
|
|
| 12/30/2020 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 13,969 shares
@ $50.77, valued at
$709.2k
Sold 5,727 shares
@ $51.75, valued at
$296.4k
Sold 3,951 shares
@ $52.68, valued at
$208.1k
Sold 1,353 shares
@ $53.54, valued at
$72.4k
Exercised 25,000 options to buy
@ $0.41, valued at
$10.3k
|
|
| 05/28/2020 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $45.99, valued at
$1.8M
|
|
| 03/13/2018 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 31,047 options
@ $11, valued at
$341.5k
|
|
| 04/26/2016 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on Mirna Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $4.42, valued at
$1.1M
|
|
|
|